Results 61 to 70 of about 1,675 (195)

Impact of Epstein‐Barr Virus Donor Serostatus on Post‐Transplant Mortality and Post‐Transplant Lymphoproliferative Disorder in Epstein‐Barr Virus Seropositive Thoracic Organ Transplant Recipients: Data from the Organ Procurement and Transplantation Network

Journal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT Donor Epstein‐Barr virus (EBV)‐seropositive (D + ) serostatus is a risk factor for post‐transplant lymphoproliferative disorder (PTLD) in EBV‐seronegative recipients. The impact of donor EBV serostatus on mortality and PTLD in EBV‐seropositive (R + ) thoracic organ transplant recipients is unknown. We analyzed 49 458 EBV R+ thoracic transplant
Khuloud Aldhaheri, Robert C. Wright, Stephen Lee, Mohsin Ali, Brian Clarke, Céline Bergeron, Allison Mah, Alissa Wright, Sara Belga   +8 more
wiley   +1 more source

POST TRANSPLANT LYMHOPROLIFERATIVE DISORDERS IN RENAL ALLOGRAFT PATIENTS

Turkish Journal of Nephrology, 2019
After organ transplantation, different clinical and histopathological forms of post transplant lymphoproliferative diseases (PTLDs) related to imniunsiipression are observed. Post transplant lymphomas within the PTLDs have different propertiescompared to
Sait ŞEN, Mine HEKİMGİL, Soner DUMAN, Ercan OK, Mehmet ÖZKAHYA, Aysın ZEYTİNOĞLU, Cüneyt HOŞÇOŞKUN   +6 more
doaj  

Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11C]DPA-713 PET

Journal of Neuroinflammation, 2018
The pathophysiology of post-treatment Lyme disease syndrome (PTLDS) may be linked to overactive immunity including aberrant activity of the brain’s resident immune cells, microglia.
Jennifer M. Coughlin, Ting Yang, Alison W. Rebman, Kathleen T. Bechtold, Yong Du, William B. Mathews, Wojciech G. Lesniak, Erica A. Mihm, Sarah M. Frey, Erica S. Marshall, Hailey B. Rosenthal, Tristan A. Reekie, Michael Kassiou, Robert F. Dannals, Mark J. Soloski, John N. Aucott, Martin G. Pomper   +16 more
doaj   +1 more source

Advances and challenges in experimental models for Epstein–Barr virus research

mLife, Volume 5, Issue 4, Page 401-416, August 2026.
Abstract Epstein–Barr virus (EBV), the first identified human oncovirus, is a ubiquitous γ‐herpesvirus etiologically linked to diverse malignancies, lymphoproliferative disorders, and autoimmune diseases. Experimental models are pivotal for unraveling the infection and pathogenesis mechanisms, life cycle regulation, as well as development and ...
Gulimire Wufuer, Jiabao Tang, Tingdong Li, Shengxiang Ge, Jun Zhang, Ningshao Xia   +5 more
wiley   +1 more source

Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation

, 2014
Previous studies of donor or recipient origin of posttransplant lymphoproliferative disorders (PTLDs) following solid organ transplantation (SOT) have either been small or with selected patient groups. We studied tumor origin in a population-based cohort
Bengtsson, Mats,, Backlin, Carin,, Pauksens, Karlis,, Kinch, Amelie,, Enblad, Gunilla,, Cavelier, Lucia,, Thunberg, Ulf,, Baecklund, Eva,, Sundström, Christer,   +8 more
core   +1 more source

Central Nervous System Infections in Pediatric Solid Organ Transplant Recipients

Pediatric Transplantation, Volume 30, Issue 8, August 2026.
CNS infections in SOT recipients are rare and presentation can be subtle. Therefore, a low threshold for evaluation is warranted to minimize the associated mortality. ABSTRACT Background Solid organ transplant (SOT) recipients face an increased risk of central nervous system (CNS) infections due to immunosuppression.
Amna AlSaihati, Kathleen E. Hosek, Cristina Otero, Brandon H. Tran, Carrie A. Mohila, David Moreno McNeill, Mini Michael, Krupa R. Mysore, Joseph A. Spinner, Claire E. Bocchini, Kristen G. Valencia Deray   +10 more
wiley   +1 more source

Infectious mononucleosis-like PTLD [PDF]

Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2018
Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of transplantation which represent a heterogeneous group of lymphoproliferative diseases and show a spectrum of clinical, morphologic, and molecular genetic features ranging from reactive polyclonal lesions to frank lymphomas. Infectious mononucleosis (IM)-
openaire   +2 more sources

Intestinal transplantation in Australia: progress, challenges and future directions

Internal Medicine Journal, Volume 56, Issue 7, Page 1182-1189, July 2026.
Abstract Background Intestinal transplant is a rare procedure reserved for patients with intestinal failure who cannot be sustained on total parenteral nutrition due to severe, life‐threatening complications. This study aims to describe the activity and outcomes of intestinal transplantation undertaken in Australia.
Brooke Chapman, Darren Wong, Graham Starkey, Marcos Perini, Jason Yap, Adam Testro   +5 more
wiley   +1 more source

Cost of illness in patients with post-treatment Lyme disease syndrome in Belgium

, 2023
Background A proportion of patients with Lyme borreliosis (LB) report long-term persisting signs and symptoms, even after recommended antibiotic treatment, which is termed post-treatment Lyme disease syndrome (PTLDS).
Verhaeghe, NickGE390019911172798020003220550000-0001-9956-4970FA17F2DE-F0ED-11E1-A9DE-61C894A0A6B4, Annemans, LievenGE398010015080050000-0001-8305-7210F61CA742-F0ED-11E1-A9DE-61C894A0A6B4, Borgermans, LiesbethGE39802002903366976C9A16-7D7A-11E8-931F-10E111A95AF2, Perronne, Christian, Willems, RubenGE390000904069298020009032470000-0001-8732-94552011FDFE-F0EE-11E1-A9DE-61C894A0A6B4   +4 more
core   +2 more sources

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease

, 2015
BACKGROUND: Lyme disease patients with erythema migrans are said to have post-treatment Lyme disease symptoms (PTLDS) if there is persistence of subjective symptoms for at least 6 months following antibiotic treatment and resolution of the skin lesion ...
Visintainer, Paul
core   +1 more source